Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine Efficacy
Research data from G. Djomand and colleagues update understanding of vaccine efficacy
June 4th, 2008
A new study, 'The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials,' is now available. According to recent research from the United States, "Successful recruitment and retention of HIV-uninfected at-risk participants are essential for HIV vaccine efficacy trials. A multicountry vaccine preparedness study was started in 2003 to assess enrollment and retention of HIV-negative high-risk participants and to assess their willingness to participate in future vaccine efficacy trials." "HIV-negative high-risk adults were recruited in the Caribbean, in Southern Africa, and in Latin America, and were followed for 1 year....
Source: Vaccine Weekly (2008-06-04)
|
